Abstract
COVID-19 can cause acute kidney injury and may cause or exacerbate chronic kidney diseases, including glomerular diseases. SARS-CoV-2 infection of kidney cells has been reported, but it remains unclear if viral infection of kidney cells causes disease. The most important causes of kidney injury in patients with COVID-19 include impaired renal perfusion and immune dysregulation. Chronic kidney disease, especially kidney failure with kidney replacement therapy and kidney transplant, is associated with markedly increased COVID-19 mortality. Persons with severe kidney disease have been excluded from most clinical trials of COVID-19 therapies, so therapeutic approaches must be extrapolated from studies of patients without kidney disease. Some medications used to treat COVID-19 should be avoided or used at reduced dosages in patients with severe kidney disease and in kidney transplant recipients. Additional research is needed to determine the optimal strategies to prevent and treat COVID-19 in patients with kidney disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-13 |
| Number of pages | 13 |
| Journal | Annual Review of Medicine |
| Volume | 74 |
| DOIs | |
| State | Published - Jan 27 2023 |
Keywords
- COVID-19
- Chronic kidney disease
- Dialysis
- ESKD
- End-stage kidney disease
- KFRT
- Kidney
- Kidney failure requiring replacement therapy
- Kidney transplant
- SARS-CoV-2
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology